Analysis of anti-PD-1/PD-L1 therapeutic effect and intestinal flora characteristics in patients with non-small cell lung cancer
10.3969/j.issn.1673-4130.2024.04.024
- VernacularTitle:非小细胞肺癌患者抗PD-1/PD-L1治疗疗效及其肠道菌群特征分析
- Author:
Shuai LI
1
;
Xue HAN
;
Wenjing MA
;
Rong XU
;
Changmin WANG
Author Information
1. 新疆维吾尔自治区人民医院检验科,新疆乌鲁木齐 830001
- Keywords:
non-small cell lung cancer;
programmed death receptor 1/programmed death ligand 1;
in-testinal flora
- From:
International Journal of Laboratory Medicine
2024;45(4):505-508,512
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the therapeutic effect of anti-programmed death receptor 1(PD-1)/pro-grammed death ligand 1(PD-L1)and the characteristics of intestinal flora in patients with non-small cell lung cancer(NSCLC).Methods A total of 81 NSCLC patients admitted to the People's Hospital of Xinjiang Uygur Autonomous Region from January 2020 to January 2022 were taken as the research object.According to the patients'immunotherapy response,the patients were divided into non-response group and response group.The differences in clinical data and intestinal flora distribution between the two groups were compared,and the correlation between PFS and intestinal flora a diversity index was analyzed by Spearman correlation.Results The proportion of smoking patients in response group was significantly lower than that in non-re-sponse group,and the difference was statistically significant(x2=4.648,P=0.031).Chao1 index,ACE index and shannon wiener index patients in non-response group were lower than those in response group,while Simpson diversity index was higher than that in response group,with statistical significance(P＜0.05).Chao1 index,ACE index and shannon wiener index were positively correlated with PFS(r=0.526,0.579 and 0.539,all P＜0.05),while Simpson diversity index was negatively correlated with PFS(r=-0.867,P＜0.001).The principal coordinate analysis was used to analyze the β diversity structure of intestinal flora.The first principal component contribution rate was 70.36％,and the second principal component contribution rate was 16.63％.Conclusion The diversity and distribution of intestinal flora in NSCLC patients are related to anti-PD-1/PD-L1 therapy.The higher the diversity of intestinal flora,the more sensitive the anti-PD-1/PD-L1 therapy.
